<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
<url>
<loc>https://dk.prisysbiotech.com/</loc>
<image:image>
<image:title>Ikke  -  Menneske  Primat  Forskning  Platform  &amp;  CRO | PRISYS  Biotek</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/logo.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/translation-research/</loc>
<image:image>
<image:title>Oversættelsesforskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/safety-evaluation/</loc>
<image:image>
<image:title>Sikkerhedsvurdering</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/biosafety-research/</loc>
<image:image>
<image:title>Forskning i biosikkerhed</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/pk-pd-adme/</loc>
<image:image>
<image:title>PK PD ADME</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/</loc>
<image:image>
<image:title>NHP Farmakologi</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/list/n20240227154733ebf63.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/pk-pd-adme/adme.html</loc>
<image:image>
<image:title>ADME</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/adme55f5d.jpg</image:loc>
</image:image>
<image:image>
<image:title>ADME</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/adme55f5d.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html</loc>
<image:image>
<image:title>Single-dose &amp; Repeated Dose Toxicity Testing</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg</image:loc>
</image:image>
<image:image>
<image:title>Single-dose &amp; Repeated Dose Toxicity Testing</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/non-human-primate.html</loc>
<image:image>
<image:title>Non-Human Primate (NHP)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg</image:loc>
</image:image>
<image:image>
<image:title>Non-Human Primate (NHP)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html</loc>
<image:image>
<image:title>Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg</image:loc>
</image:image>
<image:image>
<image:title>Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html</loc>
<image:image>
<image:title>The NHP Pharmacology Of Prisys</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg</image:loc>
</image:image>
<image:image>
<image:title>The NHP Pharmacology Of Prisys</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/biosafety-research/biosafetyresearch.html</loc>
<image:image>
<image:title>Biosafety Research</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg</image:loc>
</image:image>
<image:image>
<image:title>Biosafety Research</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html</loc>
<image:image>
<image:title>What Is A NHP Study</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/what-is-a-nhp-study0fe0f.jpg</image:loc>
</image:image>
<image:image>
<image:title>What Is A NHP Study</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/what-is-a-nhp-study0fe0f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/pulmonary-artery-hypertension-embolism9d266a3e-e0d5-46d2-85d6-aad09f286515.jpg</image:loc>
</image:image>
<image:image>
<image:title>Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/pulmonary-artery-hypertension-embolism9d266a3e-e0d5-46d2-85d6-aad09f286515.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html</loc>
<image:image>
<image:title>Coagulation/Hemostasis Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg</image:loc>
</image:image>
<image:image>
<image:title>Coagulation/Hemostasis Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html</loc>
<image:image>
<image:title>New And Modified Applications</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/new-and-modified-applicationsab01b425-decb-46a1-90d1-e5fee60f1327.jpg</image:loc>
</image:image>
<image:image>
<image:title>New And Modified Applications</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/new-and-modified-applicationsab01b425-decb-46a1-90d1-e5fee60f1327.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>Hemophilia A Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg</image:loc>
</image:image>
<image:image>
<image:title>Hemophilia A Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html</loc>
<image:image>
<image:title>NHP Asthma/atopic Dermatitis Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/nhp-asthma-atopic-dermatitis-model6bc15051-9b18-470b-a3ed-3a035fb26acc.jpg</image:loc>
</image:image>
<image:image>
<image:title>NHP Asthma/atopic Dermatitis Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/nhp-asthma-atopic-dermatitis-model6bc15051-9b18-470b-a3ed-3a035fb26acc.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/safety-evaluation/toxicology.html</loc>
<image:image>
<image:title>Toxicology</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg</image:loc>
</image:image>
<image:image>
<image:title>Toxicology</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html</loc>
<image:image>
<image:title>NHP Non-Alcoholic Steatohepatitis (NASH) Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/nhp-non-alcoholic-steatohepatitis-nash-model7332a6f4-bc77-45be-bf2b-07178c46a62a.jpg</image:loc>
</image:image>
<image:image>
<image:title>NHP Non-Alcoholic Steatohepatitis (NASH) Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/nhp-non-alcoholic-steatohepatitis-nash-model7332a6f4-bc77-45be-bf2b-07178c46a62a.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/translation-research/nhpresources.html</loc>
<image:image>
<image:title>NHP Resources</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg</image:loc>
</image:image>
<image:image>
<image:title>NHP Resources</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>Glaucoma Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/glaucoma-nonhuman-primates-disease-model092df254-f018-4636-a429-8344948a9978.jpg</image:loc>
</image:image>
<image:image>
<image:title>Glaucoma Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/glaucoma-nonhuman-primates-disease-model092df254-f018-4636-a429-8344948a9978.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html</loc>
<image:image>
<image:title>NHP Chronic Obstructive Pulmonary Disease (COPD) Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/nhp-chronic-obstructive-pulmonary-disease08000f1b-42f7-4c7d-9ba5-6f15c54993c9.jpg</image:loc>
</image:image>
<image:image>
<image:title>NHP Chronic Obstructive Pulmonary Disease (COPD) Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/nhp-chronic-obstructive-pulmonary-disease08000f1b-42f7-4c7d-9ba5-6f15c54993c9.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html</loc>
<image:image>
<image:title>Dose Range Finding Test</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-teste7c22.jpg</image:loc>
</image:image>
<image:image>
<image:title>Dose Range Finding Test</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/dose-range-finding-teste7c22.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg</image:loc>
</image:image>
<image:image>
<image:title>T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html</loc>
<image:image>
<image:title>Inflammatory Bowel Disease Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/inflammatory-bowel-nhp-disease-modelf4c414ff-a224-4634-a994-b8ba7a18a488.jpg</image:loc>
</image:image>
<image:image>
<image:title>Inflammatory Bowel Disease Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/inflammatory-bowel-nhp-disease-modelf4c414ff-a224-4634-a994-b8ba7a18a488.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>Psoriasis Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg</image:loc>
</image:image>
<image:image>
<image:title>Psoriasis Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html</loc>
<image:image>
<image:title>Multiple Sclerosis Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg</image:loc>
</image:image>
<image:image>
<image:title>Multiple Sclerosis Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html</loc>
<image:image>
<image:title>Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg</image:loc>
</image:image>
<image:image>
<image:title>Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html</loc>
<image:image>
<image:title>Myopia Hyperopia Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/myopia-hyperopia-nhp-modela0553861-d7d5-4d4f-af65-68d25533d6ef.jpg</image:loc>
</image:image>
<image:image>
<image:title>Myopia Hyperopia Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/myopia-hyperopia-nhp-modela0553861-d7d5-4d4f-af65-68d25533d6ef.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>AMD Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/amd-nonhuman-primates-disease-modelf663a012-d546-4fbb-8d78-834cea736255.jpg</image:loc>
</image:image>
<image:image>
<image:title>AMD Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/amd-nonhuman-primates-disease-modelf663a012-d546-4fbb-8d78-834cea736255.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>Uveitis Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/uveitis-nonhuman-primates-disease-model0ba7fdbf-75a4-42f7-8990-e9daa0c176b0.jpg</image:loc>
</image:image>
<image:image>
<image:title>Uveitis Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/uveitis-nonhuman-primates-disease-model0ba7fdbf-75a4-42f7-8990-e9daa0c176b0.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html</loc>
<image:image>
<image:title>Rheumatoid Arthritis Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg</image:loc>
</image:image>
<image:image>
<image:title>Rheumatoid Arthritis Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html</loc>
<image:image>
<image:title>Epilepsy Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg</image:loc>
</image:image>
<image:image>
<image:title>Epilepsy Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html</loc>
<image:image>
<image:title>Pharmacodynamics</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg</image:loc>
</image:image>
<image:image>
<image:title>Pharmacodynamics</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/translation-research/translational-studies.html</loc>
<image:image>
<image:title>Translational Studies</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/translational-studiesd565144e-fcec-4437-afeb-42982ae7bab9.jpg</image:loc>
</image:image>
<image:image>
<image:title>Translational Studies</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/translational-studiesd565144e-fcec-4437-afeb-42982ae7bab9.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/safety-evaluation/immunotoxicity.html</loc>
<image:image>
<image:title>Immunotoxicity</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/immunotoxicitya758bdcf-a01c-4970-a80d-758e345ae77f.jpg</image:loc>
</image:image>
<image:image>
<image:title>Immunotoxicity</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/immunotoxicitya758bdcf-a01c-4970-a80d-758e345ae77f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html</loc>
<image:image>
<image:title>Neuropathic Pain Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/neuropathic-pain-nhp-modela385dae9-a466-42bb-9982-13db42e0581b.jpg</image:loc>
</image:image>
<image:image>
<image:title>Neuropathic Pain Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/neuropathic-pain-nhp-modela385dae9-a466-42bb-9982-13db42e0581b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html</loc>
<image:image>
<image:title>Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke &amp; Brain Ischemia</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg</image:loc>
</image:image>
<image:image>
<image:title>Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke &amp; Brain Ischemia</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/pk-pd-adme/toxicokinetics.html</loc>
<image:image>
<image:title>Toxicokinetics</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/toxicokinetics70843.jpg</image:loc>
</image:image>
<image:image>
<image:title>Toxicokinetics</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/toxicokinetics70843.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html</loc>
<image:image>
<image:title>NHP Lung Fibrosis Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg</image:loc>
</image:image>
<image:image>
<image:title>NHP Lung Fibrosis Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>Acute Myocardial Infarction/Heart Failure Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/small/acute-myocardial-infarction-heart-failure3d3bf8b7-5a0c-4f9d-8841-7f98a51cf834.jpg</image:loc>
</image:image>
<image:image>
<image:title>Acute Myocardial Infarction/Heart Failure Nonhuman Primates Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/acute-myocardial-infarction-heart-failure3d3bf8b7-5a0c-4f9d-8841-7f98a51cf834.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html</loc>
<image:image>
<image:title>Pharmacokinetics</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/pharmacokineticsa44cd.jpg</image:loc>
</image:image>
<image:image>
<image:title>Pharmacokinetics</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/pharmacokineticsa44cd.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html</loc>
<image:image>
<image:title>NHP(monkey) Disease Models</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png</image:loc>
</image:image>
<image:image>
<image:title>NHP(monkey) Disease Models</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html</loc>
<image:image>
<image:title>ClearPoint Navigation For CNS Research</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg</image:loc>
</image:image>
<image:image>
<image:title>ClearPoint Navigation For CNS Research</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html</loc>
<image:image>
<image:title>AI-based NHP Behavior Analysis System</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png</image:loc>
</image:image>
<image:image>
<image:title>AI-based NHP Behavior Analysis System</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html</loc>
<image:image>
<image:title>Parkinson&#39;s Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg</image:loc>
</image:image>
<image:image>
<image:title>Parkinson&#39;s Disease Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/translation-research/clinical-imaging.html</loc>
<image:image>
<image:title>Klinisk billeddannelse</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg</image:loc>
</image:image>
<image:image>
<image:title>Klinisk billeddannelse</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html</loc>
<image:image>
<image:title>Immunosuppression Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg</image:loc>
</image:image>
<image:image>
<image:title>Immunosuppression Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html</loc>
<image:image>
<image:title>Hyperlipoidemia Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png</image:loc>
</image:image>
<image:image>
<image:title>Hyperlipoidemia Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html</loc>
<image:image>
<image:title>Type 1 Diabetes Mellitus Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png</image:loc>
</image:image>
<image:image>
<image:title>Type 1 Diabetes Mellitus Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html</loc>
<image:image>
<image:title>A-V Shunt Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg</image:loc>
</image:image>
<image:image>
<image:title>A-V Shunt Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html</loc>
<image:image>
<image:title>Endometriosis Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png</image:loc>
</image:image>
<image:image>
<image:title>Endometriosis Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html</loc>
<image:image>
<image:title>Type 2-diabetes mellitus-model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png</image:loc>
</image:image>
<image:image>
<image:title>Type 2-diabetes mellitus-model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html</loc>
<image:image>
<image:title>Renal Fibrosis Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg</image:loc>
</image:image>
<image:image>
<image:title>Renal Fibrosis Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html</loc>
<image:image>
<image:title>Convection-Enhanced Delivery (CED) Technology</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png</image:loc>
</image:image>
<image:image>
<image:title>Convection-Enhanced Delivery (CED) Technology</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/clearpoint/nhp-neuroscience.html</loc>
<image:image>
<image:title>NHP Neuroscience</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg</image:loc>
</image:image>
<image:image>
<image:title>NHP Neuroscience</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html</loc>
<image:image>
<image:title>Pruritus NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg</image:loc>
</image:image>
<image:image>
<image:title>Pruritus NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html</loc>
<image:image>
<image:title>Atopic Dermatitis NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg</image:loc>
</image:image>
<image:image>
<image:title>Atopic Dermatitis NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html</loc>
<image:image>
<image:title>Targeted Organ Drug Delivery Platform in NHP</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png</image:loc>
</image:image>
<image:image>
<image:title>Targeted Organ Drug Delivery Platform in NHP</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html</loc>
<image:image>
<image:title>Inflammatory Bowel Disease IBD NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png</image:loc>
</image:image>
<image:image>
<image:title>Inflammatory Bowel Disease IBD NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html</loc>
<image:image>
<image:title>AAV-α-Synuclein Overexpression NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg</image:loc>
</image:image>
<image:image>
<image:title>AAV-α-Synuclein Overexpression NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html</loc>
<image:image>
<image:title>Heart Failure NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg</image:loc>
</image:image>
<image:image>
<image:title>Heart Failure NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html</loc>
<image:image>
<image:title>Acute Lung Inflammation (ALI) NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png</image:loc>
</image:image>
<image:image>
<image:title>Acute Lung Inflammation (ALI) NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html</loc>
<image:image>
<image:title>Nose-to-Brain Drug Delivery</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg</image:loc>
</image:image>
<image:image>
<image:title>Nose-to-Brain Drug Delivery</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html</loc>
<image:image>
<image:title>Acute Hemorrhagic Shock Model NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png</image:loc>
</image:image>
<image:image>
<image:title>Acute Hemorrhagic Shock Model NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html</loc>
<image:image>
<image:title>Retinitis Pigmentosa (RP) NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png</image:loc>
</image:image>
<image:image>
<image:title>Retinitis Pigmentosa (RP) NHP Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html</loc>
<image:image>
<image:title>Liver Fibrosis Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png</image:loc>
</image:image>
<image:image>
<image:title>Liver Fibrosis Model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724312849130496.html</loc>
<image:image>
<image:title>Recap fra 2025: Hvordan Prisys omdefinerer translationel pålidelighed i NHP-forskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17557440664314880.html</loc>
<image:image>
<image:title>NHP - baseret farmakologi og farmakodynamiske tjenester|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530712474182656.html</loc>
<image:image>
<image:title>Mød Prisys Biotech på kommende EU Roadshow: september 2025</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17452036940915712.html</loc>
<image:image>
<image:title>Prisys Biotech-2025 Mid-Year Review</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17244093111395328.html</loc>
<image:image>
<image:title>Mød priser i det kommende USA-roadshow i marts 2025</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83999409.html</loc>
<image:image>
<image:title>PRISYS Årsrapport 2024: Fremme af NHP-modeller og præklinisk forskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77695215.html</loc>
<image:image>
<image:title>Prisys Biotech 2024 Q2 Nyhedsbrev - Forbedret præklinisk F&amp;U til CNS-terapi med PRISYS krydsreaktive modeller</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81120510.html</loc>
<image:image>
<image:title>Målrettet terapi for Parkinsons sygdom: Gennembrud i realtids-MR-guidet stamcelletransplantation</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202409061001122b75a.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724312709915648.html</loc>
<image:image>
<image:title>Når smerte bliver et minde: Følelsesmæssige årsager til kronisk smerte &amp; NHP Model Advantage|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724312817001472.html</loc>
<image:image>
<image:title>Multi-Endpoint Pain Assessment: The Future Of Analgesic Drug Development</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724313077163008.html</loc>
<image:image>
<image:title>Hvorfor mislykkes så mange analgetika i prækliniske forsøg? Svaret ligger i, hvordan vi måler smerte</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724295495066624.html</loc>
<image:image>
<image:title>Tidspunktdesign for blodprøvetagning i farmakokinetiske (PK) undersøgelser|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724290120737792.html</loc>
<image:image>
<image:title>PK-statistikker: Non-compartmental analyse (NCA) parametre og prækliniske applikationer</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724289872765952.html</loc>
<image:image>
<image:title>Hvorfor ikke-humane primatmodeller er kritiske for CNS-oligonukleotidterapi</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724289806787584.html</loc>
<image:image>
<image:title>Urinsyremetabolisme hos mennesker vs aber: Translationelle implikationer for lægemiddeludvikling</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724289207264256.html</loc>
<image:image>
<image:title>Ikke-Human Primate MASH-Associeret leverfibrosemodel|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724289069196288.html</loc>
<image:image>
<image:title>Hvorfor IMRI-Guided Brain Drug Delivery er afgørende for præcis målretning i NHP-undersøgelser</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674577444660224.html</loc>
<image:image>
<image:title>AI-drevet markørløst NHP 3D-adfærdsanalysesystem|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674577570980864.html</loc>
<image:image>
<image:title>LPS-Induceret akut lungebetændelse (ALI) NHP-model|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674577595409408.html</loc>
<image:image>
<image:title>HDM+SEB-induceret atopisk dermatitis (AtD)-model hos Cynomolgus-aber</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674577631585280.html</loc>
<image:image>
<image:title>En- til flere-rum PK-modeller forklaret|NHP Farmakokinetik|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674577592345600.html</loc>
<image:image>
<image:title>Sådan vælger du en pålidelig præklinisk CRO|Nøglekriterier for biotekvirksomheder|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674577416086528.html</loc>
<image:image>
<image:title>Translationel CAR-T-evaluering: In vitro-ekspertise og NHP-undersøgelsesstøtte — Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674577555317760.html</loc>
<image:image>
<image:title>Hvorfor mislykkes mere end 90 % af CNS-lægemiddelkandidater i kliniske forsøg?</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674577658897408.html</loc>
<image:image>
<image:title>Parkinsons sygdom prækliniske modeller: en guide til valg af neurotoksin, genetiske og NHP-modeller|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674577406321664.html</loc>
<image:image>
<image:title>Høj-præcisionslægemiddellevering og kunstig intelligens-drevne NHP translationelle platforme</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17629046555010048.html</loc>
<image:image>
<image:title>Th17-drevne NHP-immunologimodeller|Translationel autoimmun forskning hos Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17629047113081856.html</loc>
<image:image>
<image:title>AI-Baseret NHP BehaviorAtlas® System|3D-adfærdsanalyseplatform|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/rfp-template-for-nhp-studies-17629046650332160.html</loc>
<image:image>
<image:title>RFP-skabelon til NHP-studier|Fremskynd præklinisk forskningseffektivitet</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17629046677300224.html</loc>
<image:image>
<image:title>Cold Allodynia Pain Model i Cynomolgus Monkeys|Prisys Biotechnologies</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17629047176258560.html</loc>
<image:image>
<image:title>MRI-Guided Intracerebral Drug Delivery Platform|Prisys Biotech CNS Research</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17629047725515776.html</loc>
<image:image>
<image:title>NHP-modeller for luftvejssygdomme og platform til levering af luftvejsmedicin|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nhp-renal-biopsy-17629049418605568.html</loc>
<image:image>
<image:title>NHP nyrebiopsiplatform og modeller for nyresygdomme|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20251022172158e338d.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17629046654379008.html</loc>
<image:image>
<image:title>PK-undersøgelser og målrettet medicinlevering|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17629046623724544.html</loc>
<image:image>
<image:title>Prisys Biotechnologies' NHP Research And AI-Based Behavioural Analysis Platform</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17629046554371072.html</loc>
<image:image>
<image:title>Nasal-til-hjerne (N2B) leveringsteknologi til CNS-forskning|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17629046456706048.html</loc>
<image:image>
<image:title>SHR-2004: Et gennembrud i VTE-forebyggelse for ovariecancerpatienter – en succeshistorie af Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17539471013061632.html</loc>
<image:image>
<image:title>Cynomolgus &amp; Rhesus Monkey Models|Prisys Biotech Preclinical CRO</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202509191421539fa9b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530712315995136.html</loc>
<image:image>
<image:title>Idiopatisk lungefibrose (IPF) NHP -model|Prisys Biotech Preclinical CRO</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530712570766336.html</loc>
<image:image>
<image:title>Cynomolgus Monkey Biodistribution Studies|Prisys Biotech Preclinical CRO</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530712673887232.html</loc>
<image:image>
<image:title>Prisys Biotech NHP -modeller til hæmatologi og slagtilfælde forskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/the-importance-of-administration-volume-17530712336360448.html</loc>
<image:image>
<image:title>Betydningen af ​​administrationsvolumen i prækliniske undersøgelser|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/brain-targeted-drug-delivery-17530712380417024.html</loc>
<image:image>
<image:title>Hjerne - målrettet lægemiddelafgivelse|Prisys Biotech Præklinisk NHP -forskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530712306689024.html</loc>
<image:image>
<image:title>ADC Drug Development|Translational PK/PD -ramme i prækliniske NHP -undersøgelser</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025081814020269ffa.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17499603763602432.html</loc>
<image:image>
<image:title>NHP -smertemodeller til translationel lægemiddelopdagelse|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17499604149740544.html</loc>
<image:image>
<image:title>Serum Vs. Plasma: Valg af den optimale matrix til præklinisk bioanalyse</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17499604035134464.html</loc>
<image:image>
<image:title>Prækliniske doseringsretningslinjer: IV &amp; PO -volumen, pH og osmolaritet for nøjagtig PK i NHP'er og andre arter</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nhp-copd-model-17499603717481472.html</loc>
<image:image>
<image:title>Top KOL</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17499603806872576.html</loc>
<image:image>
<image:title>NHP akut blødningsmodel: Et afgørende værktøj til at fremskynde ny hæmatologi -lægemiddeludvikling</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17499604144595968.html</loc>
<image:image>
<image:title>Pruritus-forskning: Prisys Biotechs IL-31-inducerede NHP-model til evaluering af anti-ækbehandlinger</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17452037100200960.html</loc>
<image:image>
<image:title>En guide til vurdering af anti-Drug Antistof (ADA)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025071015011851653.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17452037131641856.html</loc>
<image:image>
<image:title>Åndedrætsbehandlinger: Prisys Biotechs integrerede NHP -platform til præklinisk forskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202507080951326501f.gif</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17452036963443712.html</loc>
<image:image>
<image:title>NHP -smertemodeller: Accelerating Analgetic Drug Development hos Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17452036834026496.html</loc>
<image:image>
<image:title>NHP -modelplatforme til understøttelse af lægemiddeludvikling i komplekse sygdomme</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/key-considerations-for-dosing-volume-17452037028914176.html</loc>
<image:image>
<image:title>Nøgleovervejelser til doseringsvolumen, pH og formulering i dyremodeller</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17452036984693760.html</loc>
<image:image>
<image:title>Engineered Exosomes: Revolutionering af lægemiddelafgivelse til CNS -lidelser - præklinisk indsigt fra Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250617131838d8cea.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17452036892075008.html</loc>
<image:image>
<image:title>Vejledningsprincipper for udvælgelse af dyrearter i nukleinsyremedicin toksikologiundersøgelser</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202506131705069d4cc.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17452036962460672.html</loc>
<image:image>
<image:title>Prisys Biotechs avancerede DSA og IMRI til hæmatologiske, vaskulære og nyresygdomsundersøgelser</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17452036841350144.html</loc>
<image:image>
<image:title>Cynomolgus Monkey Pain Models: Powering Translational Research til Breakthrough Ion Channel Therapeutics</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250605125053411da.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17452037014529024.html</loc>
<image:image>
<image:title>Fremme atopisk dermatitis forskning: Prisys Biotechs ikke-menneskelige primat (NHP) model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17452037411202048.html</loc>
<image:image>
<image:title>Prisys Biotechs NHP Atopic Dermatitis-model til anti-pruritisk lægemiddeludvikling</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374225047856128.html</loc>
<image:image>
<image:title>Design af dyreforsøg: Nøgleovervejelser til præklinisk forskningssucces</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025052317011698995.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374224831276032.html</loc>
<image:image>
<image:title>Atopisk dermatitis: Hvordan Cynomolgus Monkey Models Advance Precision Therapeutics</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374224815416320.html</loc>
<image:image>
<image:title>Astma-forskning: Hvorfor ikke-menneskelige primatmodeller er afgørende for ny udvikling af lægemidler</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250512174400b2bec.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374224887555072.html</loc>
<image:image>
<image:title>Forståelse af antisense oligonukleotid (ASO) farmakokinetik: nøglefaktorer i absorption og distribution</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202505081658273697e.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374225172538368.html</loc>
<image:image>
<image:title>NHP -inhalationsundersøgelser til biologi: Prisys specialiserede prækliniske CRO -tjenester</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025043015244899508.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374273417978880.html</loc>
<image:image>
<image:title>Avancerede prækliniske inhalationsundersøgelser: Tekniske kapaciteter og ekspertise hos Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202504291646054725d.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374224823657472.html</loc>
<image:image>
<image:title>Forståelse af farmakokinetik (PK): nøgleparametre og applikationer i lægemiddeludvikling</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374224820151296.html</loc>
<image:image>
<image:title>Intracerebroventrikulær (ICV) injektion: Præcision CNS -levering til præklinisk forskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374224809190400.html</loc>
<image:image>
<image:title>Intracerebral (ICM) injektion: Præcisionsmålretning for CNS Therapeutics - Prækliniske overvejelser</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202504180938433bda1.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374224837927936.html</loc>
<image:image>
<image:title>Intratecal (IT) injektion: En direkte CNS -leveringsrute til avancerede terapier - prækliniske overvejelser</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202504160948404ad29.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374224710263808.html</loc>
<image:image>
<image:title>Fremme af Parkinsons sygdomsundersøgelse med NHP -modellen</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202504111626379b25c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374225149731840.html</loc>
<image:image>
<image:title>Prækliniske PK\/PD -undersøgelser &amp; NHP -modeller til lægemiddeludvikling|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025040809451573e94.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17299364094108672.html</loc>
<image:image>
<image:title>Målretning af interleukin -31 (il -31): en ny grænse i autoimmun sygdomsmedicinudvikling - Prisys Biotech NHP -modeller til præklinisk researc</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295518140523520.html</loc>
<image:image>
<image:title>Ikke -klinisk immunotoksicitetsvurdering: Strategi, nøgleovervejelser og valg af metode</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/232.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295518240744448.html</loc>
<image:image>
<image:title>Mikrobiel test og dens indflydelse på ikke-humane primater i prækliniske DMPK-undersøgelser</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250325170337bc1d3.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295558588408832.html</loc>
<image:image>
<image:title>Cynomolgus Monkey Endometriosis Model til fremme af terapeutisk forskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/membranous-nephropathy-model-17295517844202496.html</loc>
<image:image>
<image:title>Fremme membranøs nefropati (MN) Lægemiddeludvikling: Prisys Biotechs Cynomolgus Monkey Model -platform</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/148.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295518122337280.html</loc>
<image:image>
<image:title>Farmakokinetik af inhalerede lægemidler: et paradigmeskift fra systemisk til lungeeksponering</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250310174924e6965.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/animal-models-for-womens-health-17295517928645632.html</loc>
<image:image>
<image:title>Prisys Biotech: Dyremodeller til kvinders sundhedsterapeutika</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202503071009566b10b.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295518112228352.html</loc>
<image:image>
<image:title>World Obesity Day|Prisys Biotech NHP Metabolic Modeller: Tjener udviklingen af ​​næste generations anti-fedmebehandlinger</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295517982090240.html</loc>
<image:image>
<image:title>Prisys Biotechs Cynomolgus Monkey Psoriasis Model: Fremme præklinisk farmakodynamik Evaluering</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17295558792717312.html</loc>
<image:image>
<image:title>Leverbiopsi: En afgørende teknik i store dyrefarmakokinetiske (PK) studier til ny lægemiddeludvikling</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025022509490064708.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295517813236736.html</loc>
<image:image>
<image:title>Integration af farmakokinetik og farmakodynamik i lægemiddeludvikling</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295518074561536.html</loc>
<image:image>
<image:title>Hvad validerer beviset for koncept (POC) i lægemiddeludvikling virkelig?</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250218092412fb5f5.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295517856523264.html</loc>
<image:image>
<image:title>Dyremodeller|Udfordringer og applikationer inden for udvikling af smertemodel</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202502141328261a025.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295558601909248.html</loc>
<image:image>
<image:title>Ikke -klinisk farmakodynamisk forskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2025021214305230811.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17244130861376512.html</loc>
<image:image>
<image:title>Valg af den ideelle ikke-menneskelige primat til toksikologiske studier: Cynomolgus macaque, rhesus macaque og marmoset</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250205142604591d8.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295517858472960.html</loc>
<image:image>
<image:title>Systemisk lupus erythematosus (SLE) og dyremodellernes rolle i terapeutisk udvikling</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250121104603461db.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295518074070016.html</loc>
<image:image>
<image:title>Ikke-menneskelig primatmodel til reumatoid arthritis (RA)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295558266217472.html</loc>
<image:image>
<image:title>Dyrehjernestereotaktiske instrumenter baseret på 3D -koordinatsystemer</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295518446380032.html</loc>
<image:image>
<image:title>Dyremodeller til in vivo -test (1): Etablering og klassificering</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250112202508b936b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83999388.html</loc>
<image:image>
<image:title>Udforskning af potentielle ruter for biologiske stoffer til at komme ind i hjernen</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202501071034417382f.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83999427.html</loc>
<image:image>
<image:title>Fremme forskning i reumatoid arthritis (RA) med ikke-menneskelige primatmodeller</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83999436.html</loc>
<image:image>
<image:title>Udforskning af dyremodeller for atopisk dermatitis lægemiddeleffektivitet</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202412301624286dab0.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83999392.html</loc>
<image:image>
<image:title>Den kritiske rolle for dyremodeller i menneskelig sygdomsforskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83999407.html</loc>
<image:image>
<image:title>Parkin-genmangel abemodel afslører nye mekanismer og terapeutiske mål for Parkinsons sygdom</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20241224162504c3c54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83999416.html</loc>
<image:image>
<image:title>Ikke-klinisk lægemiddeludviklingsvejledning: Akutte, subakutte, subkroniske og kroniske generelle toksicitetsundersøgelser</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83999433.html</loc>
<image:image>
<image:title>Innovativ næse-til-hjerne (N2B) medicinlevering: Omgå blod-hjerne-barrieren</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83999432.html</loc>
<image:image>
<image:title>Muligheder og udfordringer for minigrise som en ikke-klinisk stor dyreart</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024120911110171c55.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83062801.html</loc>
<image:image>
<image:title>Lægemiddelleveringsstrategier for hjernesygdomme</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202412030944155b417.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83096435.html</loc>
<image:image>
<image:title>Intraoperativ MR-navigation i realtid: Understøtter FDA-godkendelse af den første genterapi for AADC-mangel</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202411280914044b8c7.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83062167.html</loc>
<image:image>
<image:title>Øjentoksicitetsundersøgelser af øjendråber: Lægemiddeleksponering og sikkerhedsvurdering</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20241126163322d869c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82820676.html</loc>
<image:image>
<image:title>Prisys Biotech etablerer Cynomolgus Monkey Psoriasis-model for at fremskynde lægemiddeludvikling</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024111910582749e02.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82820689.html</loc>
<image:image>
<image:title>Omfattende ikke-menneskelige primatmodeller til forskning i nyresygdom af Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024111511090891eb1.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82820677.html</loc>
<image:image>
<image:title>Omfattende præklinisk sikkerhedsvurdering af antistof-lægemiddelkonjugater (ADC'er) i ikke-menneskelige primater</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20241111141121c84f3.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82820674.html</loc>
<image:image>
<image:title>Farmakokinetisk evaluering af antistof-lægemiddelkonjugater (ADC'er) i ikke-menneskelige primater</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202411081401283f377.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82820673.html</loc>
<image:image>
<image:title>Farmakodynamik Evaluering af ADC'er</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20241106161502bd911.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82820675.html</loc>
<image:image>
<image:title>Forståelse af DMPK af ADC-lægemidler</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20241029101148c4fbd.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82820678.html</loc>
<image:image>
<image:title>Fremskridt i udviklingen af ​​nukleinsyrelægemidler og Prisys Biotechs forskningskapacitet</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024101713330113621.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82347725.html</loc>
<image:image>
<image:title>Fremskridt inden for mRNA-pulmonale leveringssystemer og Prisys biotechs innovative tjenester</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20241014090616a9ff8.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82820687.html</loc>
<image:image>
<image:title>Hvorfor blev Nobelprisen i fysiologi eller medicin i 2024 tildelt disse to videnskabsmænd, der studerede mikroRNA?</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20241008113621e90e6.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82821257.html</loc>
<image:image>
<image:title>Farmakokinetiske (PK) overvejelser for lægemidler til centralnervesystemet (CNS).</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024092913295797d3f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656475.html</loc>
<image:image>
<image:title>Fremskridt inden for CNS-forskning: Prisys Biotechs MRI-kompatible hjerneinjektionssystem og CED-teknologi</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202408062147375802b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81120870.html</loc>
<image:image>
<image:title>Fremme af blødning og koagulering terapeutiske innovationer med Cynomolgus Monkey MCAO-model</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81120511.html</loc>
<image:image>
<image:title>DMPK-evaluering af lægemidler til centralnervesystemet (CNS).</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240924110059a8fdd.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/animal-models-of-human-diseases-81120506.html</loc>
<image:image>
<image:title>Dyremodeller af menneskelige sygdomme</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240920153353a85bd.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81120507.html</loc>
<image:image>
<image:title>Innovationer i smerteevaluering: AI-drevet adfærdsanalyse</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024091816220958caa.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/china-experimental-monkey-industry-81120508.html</loc>
<image:image>
<image:title>Historie, nuværende status, udfordringer og muligheder for Kinas eksperimentelle abeindustri</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240909130237c0dc8.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/human-disease-animal-models-81120503.html</loc>
<image:image>
<image:title>Menneskelige sygdomsdyremodeller: Et afgørende værktøj til at fremme biomedicinsk forskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240904101437e1414.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81120504.html</loc>
<image:image>
<image:title>Betydningen af ​​præklinisk farmakodynamik i lægemiddeludvikling|Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202408281439443e4db.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81120502.html</loc>
<image:image>
<image:title>Intranasal administration i dyreforsøg</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240827104336fadf5.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410646.html</loc>
<image:image>
<image:title>Revolutionerende CNS-lægemiddeludvikling: PRISYS Biotech introducerer IMRI-teknologi</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/convection-enhanced-delivery-81120500.html</loc>
<image:image>
<image:title>Advancing Precision Medicine: Convection-Enhanced Delivery (CED)-teknologi af Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240822125521f1687.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81120501.html</loc>
<image:image>
<image:title>Cynomolgus Monkey Chronic Kidney Disease (CKD) Model af Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79527348.html</loc>
<image:image>
<image:title>Ikke-klinisk sikkerhedsvurdering af øjenlægemiddeltilførsel ved brug af Cynomolgus makaker</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080116325669291.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/compartment-pk-model-81120514.html</loc>
<image:image>
<image:title>Forståelse af rum- og ikke-rumsmodeller i farmakokinetik</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202408121135341dcc9.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79527347.html</loc>
<image:image>
<image:title>AAV's rolle i genterapi: immunresponser og toksicitet</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801163452493e1.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81120505.html</loc>
<image:image>
<image:title>Avancerede CNS-leveringsteknikker hos Cynomolgus-aber: Accelerering af oligonukleotid-lægemiddeludvikling</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240809165539b61ef.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79527355.html</loc>
<image:image>
<image:title>Optimerede ikke-kliniske immunogenicitetsevalueringsstrategier</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080116353273f4d.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79527353.html</loc>
<image:image>
<image:title>Reduktion af brugen af ​​ikke-menneskelige primater i ikke-kliniske sikkerhedsvurderinger: Perspektiver fra FDA og industrien</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801163624dabc0.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79527390.html</loc>
<image:image>
<image:title>LCMS præklinisk bioanalyse af LNP-baserede genterapilægemidler</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801181230b6a27.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/mrna-based-therapies-past-79527386.html</loc>
<image:image>
<image:title>MRNA-baserede terapier: Tidligere</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080118112364d2d.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pk-strategies-of-pdc-79527349.html</loc>
<image:image>
<image:title>Farmakokinetiske undersøgelsesstrategier for peptid-lægemiddelkonjugater (PDC'er)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080109123097cb8.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79527388.html</loc>
<image:image>
<image:title>Farmakodynamisk (PD) evaluering af genterapi</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801180623d1663.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527378.html</loc>
<image:image>
<image:title>Farmakokinetik og bioanalyse af oligonukleotidlægemidler-(1)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801180452c5c2a.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527385.html</loc>
<image:image>
<image:title>Farmakokinetik og bioanalyse af oligonukleotidlægemidler: Absorptions- og plasmafarmakokinetik (PK) karakteristika</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801180317bc744.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79527382.html</loc>
<image:image>
<image:title>Faktorer, der skal overvejes for immunogeniciteten af ​​oligonukleotidlægemidler</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202408011801502cfb9.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79527393.html</loc>
<image:image>
<image:title>MRNA: Et kraftfuldt og alsidigt værktøj til bekæmpelse af sygdomme-Prisys-Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202408011756272a013.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79527383.html</loc>
<image:image>
<image:title>Kinesiske videnskabsmænd tilbyder nye strategier til at vende kernesymptomer på Parkinsons sygdom</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801175516ecb8a.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79527367.html</loc>
<image:image>
<image:title>Prisys Bioteknologi: Nye lipid-nanopartikler til MRNA-levering i primater</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080117542971a31.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79527372.html</loc>
<image:image>
<image:title>Vigtigheden af ​​translationel medicinsk forskning fra grundforskning til kliniske studier</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801175156b8ed0.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79527376.html</loc>
<image:image>
<image:title>De vigtigste faktorer, der tages i betragtning i WOE-analyse</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801175020842f8.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79527371.html</loc>
<image:image>
<image:title>Hvordan leverer man biologi til hjernen?</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801174910a58bb.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79527360.html</loc>
<image:image>
<image:title>Hvordan lægemidler bevæger sig og ændrer sig i vores kroppe: En kort introduktion til farmakokinetik</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202408011748076fca9.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79527374.html</loc>
<image:image>
<image:title>Hvordan man udvikler nye lægemidler hurtigere og sikrere: En guide til prækliniske DMPK-studier</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080117445005c7b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79527380.html</loc>
<image:image>
<image:title>Retningslinjer for gruppeophold for laboratorieaber</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080117440822f67.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79527365.html</loc>
<image:image>
<image:title>Eksperimentelle abers vitale rolle i at fremme videnskabelig forskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801174211d2a1b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79527375.html</loc>
<image:image>
<image:title>Forståelse af Macaca Fascicularis (Cynomolgus Monkey): Nøglekarakteristika og bidrag til biomedicinsk forskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801174043f9c14.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79527366.html</loc>
<image:image>
<image:title>Revolutionerende metabolisk sygdomsbehandling: fremskridt og udfordringer i udvikling af peptidlægemidler</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080117395084c9b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79527363.html</loc>
<image:image>
<image:title>Hvordan evaluerer man sikkerheden af ​​hudprodukter før kliniske forsøg?</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801173853b9e8e.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79527379.html</loc>
<image:image>
<image:title>Eksperimentelle abers betydningsfulde rolle i innovativ lægemiddeludvikling: Et indvendigt kig på virksomheden</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801173640dbcdb.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79527369.html</loc>
<image:image>
<image:title>Levertoksicitet som en central bekymring for SiRNA-lægemidler: En omfattende analysemålspecificitet: SiRNA's tveæggede sværd</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801173252513ea.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79527370.html</loc>
<image:image>
<image:title>Fremskridt SiRNA Terapi: Overvindelse Udfordringer i Lægemiddel Udvikling</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080117311060b15.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79527352.html</loc>
<image:image>
<image:title>Anvendelsesmuligheder for genlægemidler baseret på lipidnanopartikler</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801172808b0a45.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79527357.html</loc>
<image:image>
<image:title>Nøglepunkter i design af strategier for ikke-kliniske undersøgelser på unge dyr</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801172702f375a.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79527358.html</loc>
<image:image>
<image:title>Indsigt i de sensoriske og adfærdsmæssige træk hos ikke-menneskelige primater (NHP'er)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080117261321519.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79527373.html</loc>
<image:image>
<image:title>Ikke-klinisk undersøgelse Evaluering Q&amp;A</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801172429e1895.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/significance-principles-and-requirements-of-79527381.html</loc>
<image:image>
<image:title>Betydning, principper og krav til sikkerhedsfarmakologisk forskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080117231644f61.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79527350.html</loc>
<image:image>
<image:title>Hvordan evaluerer man præklinisk farmakologisk effekt?</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801172217a2b22.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79527342.html</loc>
<image:image>
<image:title>Refleksioner over ikke-kliniske farmakologiske undersøgelser og evaluering af terapeutiske lægemidler til ikke-alkoholisk Steatohepatitis (NASH)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202408011720005c93e.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79527351.html</loc>
<image:image>
<image:title>Fremme CNS- og CGT-forskning: Prisys Bioteknologier fører vejen</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202408011718404c246.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79527346.html</loc>
<image:image>
<image:title>Retningslinjer for indsamling af ikke-menneskelige primater cerebrospinalvæske</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801171318f7961.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79528285.html</loc>
<image:image>
<image:title>Overvejelser til fortolkning af klinisk patologisk data hos ikke-menneskelige primater (NHP'er) og hjørnetænder</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080117122736428.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79527336.html</loc>
<image:image>
<image:title>​​​Integration af CNS-sikkerhedsevaluering i generelle toksikologiske undersøgelser</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080117110558056.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79527359.html</loc>
<image:image>
<image:title>Hvordan udfører man præklinisk farmakologi/toksikologisk evaluering af ADC'er?</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801170828e5c98.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79527391.html</loc>
<image:image>
<image:title>ADME-indsigt for oligonukleotidlægemidler (1) - Absorption, distribution</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202408011705192b402.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79529086.html</loc>
<image:image>
<image:title>ADME-indsigt for oligonukleotidlægemidler (2) - Metabolisme og udskillelse</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801164818e22a4.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79527335.html</loc>
<image:image>
<image:title>Prækliniske dyreforsøg (1) - Dyrearter</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202408011646162c426.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79527345.html</loc>
<image:image>
<image:title>Klinisk patologi Datafortolkning Udfordringer og strategier i prækliniske undersøgelser af hunde og ikke-menneskelige primater</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801164503e9bd9.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79527364.html</loc>
<image:image>
<image:title>Prækliniske dyreforsøg (2) - Indgivelsesveje og -mængder</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240801163712d0df1.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/mrna-based-therapies-present-79527392.html</loc>
<image:image>
<image:title>MRNA-baserede terapier: Nuværende</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080118104113739.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79527389.html</loc>
<image:image>
<image:title>MRNA-baserede terapier: Fremtid og udfordringer</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024080118092133eb2.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79527384.html</loc>
<image:image>
<image:title>Kort introduktion om biologisk analyse af genterapi</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202408011807079dc4e.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410649.html</loc>
<image:image>
<image:title>Cynomolgus Monkey i Ophthalmic Drug Research</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024072509180742b12.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410647.html</loc>
<image:image>
<image:title>Translationelle og krydsreaktive undersøgelser med Prisys' NHP-modeller af immunologi og inflammation</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024072212200879ff1.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79186575.html</loc>
<image:image>
<image:title>Ikke-naive NHP'er i prækliniske forsøg: En omkostningseffektiv løsning af Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024071618013071b40.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nhp-asthma-model-79186581.html</loc>
<image:image>
<image:title>NHP Astmamodel: Styrkelse af prækliniske lægemiddeleffektivitetsstudier med Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202407051359254acc6.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79186580.html</loc>
<image:image>
<image:title>Fremme immunologi og inflammationsforskning med Cynomolgus Macaques-modeller - Prisys Biotechnologies</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240703110911ef80e.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79186577.html</loc>
<image:image>
<image:title>Direkte levering af oligonukleotidlægemidler til CNS og almindelige histopatologiske ændringer</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202406131052303d31d.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79186576.html</loc>
<image:image>
<image:title>Intra-Cerebrovaskulær Stroke (ICH) model af Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240607164926587f9.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75161551.html</loc>
<image:image>
<image:title>Ikke-klinisk farmakodynamisk forskning: Et væsentligt aspekt i udviklingen af ​​SiRNA-lægemidler</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202402211320123fe5b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77695193.html</loc>
<image:image>
<image:title>MR-styret stordyrs centralnervesystem præcisionslokalisering og leveringssystem sætter sig i Prisys Biotech</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77051957.html</loc>
<image:image>
<image:title>Innovative løsninger til fremme af respiratorisk terapi</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74782733.html</loc>
<image:image>
<image:title>Prisys: Advancing Animal Experimentation Through Cynomolgus Makaque Studies</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202402271423376ec81.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76173349.html</loc>
<image:image>
<image:title>Prisys opnår fuld akkreditering fra AAALAC International: En milepæl i at sikre høje standarder for laboratoriedyrspleje.</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/265.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74654547.html</loc>
<image:image>
<image:title>Forøger nukleinsyreterapi gennem banebrydende med Prisys Biotech ikke-menneskelige primatmodeller</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202401261332041ba3c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74239405.html</loc>
<image:image>
<image:title>Revolutionerende CNS-lægemiddellevering: Prisys og løftet om intrathekal injektion</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240111101138bd6a1.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75161545.html</loc>
<image:image>
<image:title>Prisys Biotech 2024 Q1 Newsletter - din pålidelige NonHuman Primate-studiespecialist</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73525467.html</loc>
<image:image>
<image:title>Hvordan ultralydsstyret leverbiopsi forbedrer makakbaseret forskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202312211047254501881.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73525466.html</loc>
<image:image>
<image:title>Retningslinjer for livslang brug af ikke-menneskelige primater i biomedicinsk forskning: A Prisys Biotechnology Perspective</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202402271428388db72.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73001103.html</loc>
<image:image>
<image:title>Ikke-menneskelige primater: En kort introduktion til deres biologiske egenskaber</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n202402271431193773d.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72673651.html</loc>
<image:image>
<image:title>Udstillingsanmeldelser|Prisys Biotech skinner på det årlige møde i American Society for Neuroscience (SfN 2023)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321068.html</loc>
<image:image>
<image:title>Mød Prisys Biotech på Society For Neurosciences årsmøde (SfN 2023)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321066.html</loc>
<image:image>
<image:title>Verdens slagtilfældedag|Fokus på iskæmisk slagtilfælde dyremodeller og farmakologi</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202310292017544133660.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321063.html</loc>
<image:image>
<image:title>Prisys Biotech inviterer dig til at deltage i SAPA-Kina årsmøde i 2023</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321065.html</loc>
<image:image>
<image:title>Verdens Alzheimersdag|Udfordringerne og løsningerne til AD Drug Development</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202309211504565472671.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321062.html</loc>
<image:image>
<image:title>Prisys Biotechs Cynomolgus Macaque-dyremodel hjælper med udviklingen af ​​nye antikoagulerende lægemidler</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202309182207050266461.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70945719.html</loc>
<image:image>
<image:title>Prisys: Leverer dyreforsøgsservice af høj kvalitet til det nye anti-koagulationsfaktor XI-antistof BJTJ-1837</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202308311332528401166.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70941350.html</loc>
<image:image>
<image:title>Metode til etablering af en Cynomolgus-abemodel af hypertriglyceridæmi og dens anvendelse</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202308212156285814136.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70941352.html</loc>
<image:image>
<image:title>Farmakologi: Hovedparametre og betydning af farmakokinetik (PK)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202308091145033318894.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70941351.html</loc>
<image:image>
<image:title>Præklinisk farmakologisk evaluering af onkolytiske viruslægemidler</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202308071041585027430.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/0-70941353.html</loc>
<image:image>
<image:title>Hvordan små nukleinsyrelægemidler kan transformere behandlingen af ​​CNS-sygdomme: Indsigt fra Prisys Biotechnology, en førende CRO-leverandør af NHP-sygdomsmodeller</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202308041018581481730.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70941361.html</loc>
<image:image>
<image:title>Farmakokinetik, forskningsstrategier og casestudier af peptidlægemidler</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202308031715493686411.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69654954.html</loc>
<image:image>
<image:title>Nøgle forskningspunkter for ADC Drug PK</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202307302137108622628.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69653835.html</loc>
<image:image>
<image:title>Prisys Biotechnology: En leder i NHP CNS Disease Modeling Research Platform</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309317.html</loc>
<image:image>
<image:title>Sådan taber du dig og kontrollerer diabetes med GLP-1-produkter</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202307162139405018976.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309282.html</loc>
<image:image>
<image:title>Hvordan China Monkey hjælper med at udføre præklinisk forskningseffektivitet?</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240227143532bd79a.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309312.html</loc>
<image:image>
<image:title>Hvad er effektiviteten af ​​RNAi?</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202307092210201669077.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309297.html</loc>
<image:image>
<image:title>Prisys Biotech Store dyreforsøg Public Service Platform: Lavpris og højeffektiv løsning til store dyreforsøg</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n2024022714394317bcf.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69143845.html</loc>
<image:image>
<image:title>Hvordan AAV-genterapi kan redde dit syn: De seneste gennembrud fra ikke-menneskelige primatstudier</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202307022231508642715.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69143850.html</loc>
<image:image>
<image:title>Prisys Biotech fremviser ikke-menneskelig primatmodelplatform på årsmødet i Japanese Society of Toxicology</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69143846.html</loc>
<image:image>
<image:title>Den lovende fremtid for AAV-genterapi hos ikke-menneskelige primater</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202306232107539553735.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69143847.html</loc>
<image:image>
<image:title>Hvad er lipid-nanopartikler til genterapi?</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202306182144004132789.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69143849.html</loc>
<image:image>
<image:title>Prisys Biotech inviterer dig til at deltage i det 50. årsmøde i The Japanese Society of Toxicology (JSOT)</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69143848.html</loc>
<image:image>
<image:title>Immunotoksicitetstest, lægemiddelsikkerhedsevaluering-PRISYS BIOTECH</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202306102132091628389.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68307252.html</loc>
<image:image>
<image:title>En optimal dyremodel af iskæmisk slagtilfælde etableret ved digital subtraktion Angiografi-guidede autologe tromber hos Cynomolgus-aber</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68102640.html</loc>
<image:image>
<image:title>Hvorfor du bør bekymre dig om ikke-menneskelige primater i forskning og udvikling af nukleinsyrelægemiddelleveringssystem</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202305282122338248983.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68102645.html</loc>
<image:image>
<image:title>Mød Prisys Biotech ved den 70. JALAS 2023!</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68102646.html</loc>
<image:image>
<image:title>Genterapi skinner med nye godkendelser til sjældne sygdomme</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202305162133347179081.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68102643.html</loc>
<image:image>
<image:title>Revolutionerende lægemiddelopdagelse: Hvordan ikke-menneskelige primater optimerer SiRNA-screening for hurtigere og mere effektive resultater</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/39406/news/n20240227144111404cb.png</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67237985.html</loc>
<image:image>
<image:title>Maksimering af SiRNA-farmakologieffektivitet med ikke-menneskelig primatforskning</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202305022215194112233.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67237984.html</loc>
<image:image>
<image:title>Hvordan ikke-menneskelige primater kan revolutionere SiRNA-forskning: En omfattende guide</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202304272138362221911.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67237983.html</loc>
<image:image>
<image:title>Fejring af verdensdagen for forsøgsdyr: Hvorfor Prisys er forpligtet til at fremme sundheden for ikke-menneskelige primater</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67237982.html</loc>
<image:image>
<image:title>Maksimering af CRISPR/Cas9-forskningseffektivitet med ikke-menneskelige primatmodeller</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202304221149520486556.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67237981.html</loc>
<image:image>
<image:title>Frigør det terapeutiske potentiale: Hvorfor investering i nukleinsyremedicin er fremtiden for medicin</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202304200850383332884.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67237979.html</loc>
<image:image>
<image:title>Frigørelse af potentialet for ikke-menneskelige primater til at forbedre genterapi-opdagelsen af ​​lægemiddelmål</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202304142148160397375.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/world-parkinsons-disease-day-67237980.html</loc>
<image:image>
<image:title>Unite For Parkinsons: Forenede hænder for at øge bevidstheden om World Parkinsons Disease Day</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67237978.html</loc>
<image:image>
<image:title>Sådan bruges ikke-menneskelige primater effektivt i genterapisikkerhedsevaluering</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202304102117431547381.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/gene-therapy-toxicology-66267727.html</loc>
<image:image>
<image:title>Genterapi toksikologisk forskning med Nonhuam Primate</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202304052050241172289.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66085922.html</loc>
<image:image>
<image:title>En omfattende guide til udførelse af DMPK-undersøgelse til genterapi</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202303292053463875854.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/gene-therapy-nhp-model-66085917.html</loc>
<image:image>
<image:title>Revolutionerende medicinsk forskning: Genterapi-gennembrud i ikke-menneskelige primatsygdomsmodeller!</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202303282057377312705.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66085918.html</loc>
<image:image>
<image:title>Top 10 populære spørgsmål relateret til genterapi</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202303241229248740600.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66085916.html</loc>
<image:image>
<image:title>Prisys Biotech: Ikke-menneskelig primatfarmakologi til genterapi</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202303241128310077112.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66085915.html</loc>
<image:image>
<image:title>Supporting Women's Health: A Look Into Endometriosis</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-sot2023-66085919.html</loc>
<image:image>
<image:title>PRISYS og Taichu Group samarbejder om SOT-udstillingen i 2023</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66085914.html</loc>
<image:image>
<image:title>Har vi brug for yderligere undersøgelser til smertevurdering? - NHP</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202303081329477852711.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66085913.html</loc>
<image:image>
<image:title>Vær med til at fejre World Wildlife Day</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66085912.html</loc>
<image:image>
<image:title>Prisys Shanghai NHP R&amp;D Center lanceres og markerer en milepæl inden for farmaceutisk forskning og udvikling i Kina</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://dk.prisysbiotech.com/news/meetprisys-sot2023-66085911.html</loc>
<image:image>
<image:title>Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow</image:title>
<image:loc>https://dk.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg</image:loc>
</image:image>
</url>
</urlset>